PK BIOTECH ApS: Financial statements 2022
CVR: 25671988
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
PK BIOTECH ApS (CVR 25671988) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK 8,819,761 compared with DKK 17,095,029 the year before. Equity in the 2022 report amounted to DKK 141,402,090. The solvency ratio was 75.8%. The company had 1 employee in the financial year.
- Profit/Loss
- DKK 8,819,761
- Equity
- DKK 141,402,090
- Total Assets
- DKK 186,455,359
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | - | 8.8 mio. | 141.4 mio. | 1 |
| 2021 | - | 0 | 17.1 mio. | 121.2 mio. | 1 |
| 2020 | - | 3.6 mio. | 27.8 mio. | 103.9 mio. | 1 |
| 2019 | - | -19 t. | 22.8 mio. | 75.9 mio. | 1 |
| 2018 | - | - | 7.3 mio. | 52.9 mio. | 1 |
Official annual report
Keep an eye on PK BIOTECH ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
PK BIOTECH ApS has published its annual report for 2021. Gross profit came to DKK 0, and the net result was DKK 17,095,029.
About PK BIOTECH ApS
PK BIOTECH ApS is a Danish company of the type Anpartsselskab based in Lille Skensved, founded in 2000. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named ApS KBUS 8 NR. 5426. The management consists of Aaron Michael Wong. The board consists of Aaron Michael Wong (chair), Michael Frederik Ryde and Stig Løkke Pedersen. The company is owned by Magle CHemoswed Holding AB. According to the 2025 annual report, the company had an average of 60 employees. In 2025, the company reported a gross profit of DKK -92,700 and a net result of DKK -70,784,803 compared with DKK -22,344,445 the year before. Equity in the 2025 report amounted to DKK 32,814,517.